Themotaxis of metastatic tumor cells (original) (raw)
References
Postlethwaite AE, Snyderman R, Kang AH: The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med 144: 1188–1203, 1976. Google Scholar
Postlethwaite AE, Seyer JM, Kang AH: Chemotactic attraction of human fibroblasts to types I, II and III collagen and collagen-derived peptides. Proc Natl Acad Sci USA 75: 871–875, 1978. Google Scholar
Postlethwaite AW, Snyderman R, Kang AH: Generation of fibroblast chemotactic factor in serum by activation of complement. J Clin Invest 64: 1379–1385, 1979. Google Scholar
Hayashi H, Yoshida K, Ozaki T, Ushijima K: Chemotactic factor associated with invasion of cancer cells. Nature 226: 174–175, 1970. Google Scholar
Yoshida K, Ozaki T, Ushijima K, Hayashi H: Studies on the mechanism of invasion in cancer. I: Isolation and purification of a factor chemotactic for cancer cells. Int J Cancer 6: 123–132, 1970. Google Scholar
Romualdez AG, Ward PA: A unique, complement-derived chemotactic factor for tumor cells. Proc Natl Acad Sci USA 72: 4128–4132, 1975. Google Scholar
Romualdez AG, Ward PA, Torikata T: Relationship between the C5 peptides chemotactic for leukocytes and tumor cells. J Immunol 117: 1762–1766, 1975. Google Scholar
Orr W, Varani J, Ward PA: Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement. Am J Pathol 93: 405–422, 1978. Google Scholar
Orr W, Varani J, Gondek MD, Ward PA, Mundy GR: Chemotactic responses of tumor cells to products of resorbing bone. Science 203: 176–179, 1979. Google Scholar
Mundy GR, DeMartino S, Rowe DE: Collagen and collagen-derived fragments are chemotactic for tumor cells. J Clin Invest 68: 1102–1105, 1981. Google Scholar
O'Flaherty JT, Kreutzer DL, Ward PA: Neutrophil aggregation and swelling induced by chemotactic agents. J Immunol 119: 232–239, 1977. Google Scholar
O'Flaherty JT, Kreutzer DL, Ward PA: Chemotactic factor influences on the aggregation, swelling and foreign surface adhesiveness of human leukocytes. Am J Pathol 90: 537–550, 1978. Google Scholar
O'Flaherty JT, Kreutzer DL, Ward PA: The influence of chemotactic factors on neutrophil adhesiveness. Inflammation 3: 37–48, 1978. Google Scholar
Becker EL, Showell HJ: The ability of chemotactic factors to induce lysosomal enzyme release. II: The mechanism of the release. J Immunol 112: 2055–2066, 1974. Google Scholar
Becker EL, Sigman M, Oliver JM: Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187. The nature of the receptor and the requirement for Ca+2. Am J Pathol 95: 81–97, 1979. Google Scholar
Wass JA, Varani J, Ward PA: Size increase induced in Walker ascites cells by chemotactic factors. Cancer Letters 9: 313–318, 1980. Google Scholar
Wass JA, Varani J, Piontek GE, Goff D, Ward PA: Characteristics of the chemotactic factor-mediated cell swelling response of tumor cells. J Natl Cancer Inst 66: 927–933, 1981. Google Scholar
Varani J, Wass J, Piontek G, Ward PA: Chemotactic factor-induced adherence of tumor cells. Cell Biol Int Rep 5: 525–530, 1981. Google Scholar
Varani J, Fantone JC: Phorbol myristate acetate-induced adherence of Walker 256 carcinosarcoma cells. Cancer Res (in press).
Kreutzer DL, O'Flaherty JT, Orr W, Showell HJ, Ward PA, Becker EL: Quantitative comparisons of various biological responses of neutrophils to different active and inactive chemotactic factors. Immunopharmacology 1: 39–47, 1978. Google Scholar
Marasco WA, Becker EL, Oliver JM: The ionic basis of chemotaxis: separate requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide. Am J Pathol 98: 749–768, 1980. Google Scholar
Ushijima K, Nishi A, Ishikura A, Hayashi H: Characterization of two different factors chemotactic for cancer cell from tumor tissue. Virchows Arch B: 21: 119–131, 1976. Google Scholar
Orr FW, Varani J, Gondek MD, Ward PA, Mundy GR: Partial characterization of a bone-derived chemotactic factor for tumor cells. Am J Pathol (99):43–52, 1980.
Wass JA, Varani J, Piontek GE, Ward PA, Orr FW: Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide. Cell Differ (in press).
Orr W, Phan S, Varani J, Ward PA, Kreutzer DL, Webster RO, Henson PM: Chemotactic factor for tumor cells derived from the C5a fragment of complement component 5. Proc Natl Acad Sci USA 76: 1986–1989, 1979. Google Scholar
Koono M, Ushijima K, Hayashi H: Studies on the mechanisms of invasion in cancer. III: Purification of a neutral protease of rat ascites hepatoma cells associated with production of a chemotactic factor for cancer cells. Int J Cancer 13: 105–113, 1974. Google Scholar
Koono M, Katsuya H, Hayashi H: Studies on the mechanisms of invasion in cancer. IV: A factor associated with release of a neutral protease from tumor cells. Int J Cancer 13: 334–342, 1974. Google Scholar
Orr FW, Varani J, Kreutzer DL, Senior RM, Ward PA: Digestion of the fifth component of complement by leukocyte enzymes: sequential generation of chemotactic activities for leukocytes and for tumor cells. Am J Pathol 94: 75–84, 1979. Google Scholar
Showell HJ, Freer RJ, Zigmond SN, Shiffmann E, Aswanikumar I, Corcoran B, Becker EL: The structure—activity relations of synthetic peptides as chemotactic factors and inducers of lysozomal enzyme secretions for neutrophils. J Exp Med 143: 1454–1469, 1968. Google Scholar
Briles EB, Kornfeld S: Isolation and metastatic properties of detachment variants of B16 melanoma cells. J Natl Cancer Inst 60: 1217–1222, 1978. Google Scholar
Fidler IJ: Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35: 218–224, 1975. Google Scholar
Hart IR: The selection and characterization of an invasive variant of the B16 melanoma. Am J Path 97: 585–600, 1979. Google Scholar
Nicolson GL, Winkelhake JL: Organ specificity of blood borne metastases as determined by cell adhesion. Nature 225: 230–232, 1975. Google Scholar
Varani J, Lovett EJ, Elgebaly S, Lundy J, Ward PA: In vitro and in vivo adherence of tumor cell variants correlated with tumor formation. Am J Pathol 101: 345–352, 1980. Google Scholar
Winklehake JL, Nicolson GL: Determination of adhesive properties of variant metastatic melanoma cells to BALB/3T3 cells and their virus-transformed derivatives by a monoayer attachment assay. J Natl Cancer Inst 56: 285–291, 1976. Google Scholar
MacGregor R, Spagnuolo P, Lentnek A: Inhibition of gramulocyte adherence by ethanol, prednisone and aspirin measured with an assay system. New England J Med 291: 642–646, 1974. Google Scholar
Orr FW, Varani J, Delikatny J, Jain N, Ward PA: Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy. Am J Pathol 102: 160–167, 1981. Google Scholar
Elgebaly S, Kunkel S, Lovett EJ, Varani J: cAMP differences between clones of high and low malignant fibrosarcoma cells. Oncology (in press).
Lovett EJ, Dickinson RW, Varani J: Metastatic variants from a methylcholanthrene-induced syngeneic murine fibrosacoma produces immunosuppression proportional to the metastatic potential of the variant. In: Jeney A, Lapis K (eds) The proceedings of the 6th meeting of the european association for cancer research. Amsterdam, Kugler (in press).
Castagna, Rochette-Egly C, Rosenfeld C: Tumor promoting phorbol diester induces substrate adhesion and growth inhibition in lymphoblastoid cells. Cancer Letters 6: 227–234, 2979.
Lowe ME, Pacifici M, Holtzner H: Effect of phorbol-12-myristate-13-acetate on the phenotypic program of cultural chondroblasts and fibroblasts. Cancer Res 38: 2350–2356, 1978. Google Scholar
Yamasaki H, Weinstein B, Fibach E, Rifkind R, Marks PA: Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells. Cancer Res 39: 1989–1994, 1979. Google Scholar
Koffler HP, Bar-Eli M, Territo MC: Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res 41: 919–926, 1981. Google Scholar
Suss R, Kreibich B, Kinzel V: Phorbol esters as a tool in cell research? Eur J Cancer 8: 299–304, 1972. Google Scholar
O'Flaherty JT, Showell HJ, Ward PA, Becker EL: A possible role of arachidonic acid in human neutrophil aggregation and degranulation. Am J Pathol 96: 799–810, 1979. Google Scholar
O'Flaherty JT, Showell HJ, Becker EL, Ward PA: Neutrophil aggregation and degranulation. Effect of arachidonic acid. Am J Pathol 95: 433–444. 1979. Google Scholar
Smolen JE, Weismann G: Effects of indomethacin, 5, 8, 11, 14-eicosatetraynoic acid and p-bromophenacyl bromide on lysozomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. Biochem Pharmacol 29: 533–538, 1980. Google Scholar
Wertz PE, Mueller GC: Rapid stimulation of phospholipid metabolism in bovine lymphocytes by tumor-promoting phorbol esters. Cancer Res 38: 2900–2904, 1978. Google Scholar
Wertz PE, Mueller GC: Inhibition of 12–0-tetradecanoyl-phorbol 13-acetate-accelerated phospholipid metabolism by 5, 8, 11, 14-eicosatetrynoic acid. Cancer Res 40: 776–781, 1980. Google Scholar
Levine L, Hassid A: Effects of phobol-12, 13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cells. Biochem Biophys Res Comm 79: 477–484, 1977. Google Scholar
Goetzl EJ, Sun FF: Generation of unique mono-hydroxieicosatetraenoic acids from arachidonic acid by human neutrophils. J Exp Med 150: 406–411, 1979. Google Scholar
Borgeat P, Samuelsson B: Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci USA 76: 2148–2152, 1979. Google Scholar
Hugteren DH: Arachidonate lipoxygenase in blood platelets. Biochem Biophys Acta 380: 299–307, 1975. Google Scholar
Borgeat P, Samuelsson B: Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxi-eicosatetraenoic acid. J Biol Chem 254: 2643–2646, 1979. Google Scholar
Borgeat P, Samuelsson B: Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxi acids. Proc Natl Acad Sci USA 76: 3213–3217, 1979. Google Scholar
Wass JA, Rao KMK, Varani J, Ward PA: Effects of chemotactic factors on the mobility of Concanavalin-A receptors in membranes. Cell Biophys (submitted for publication).
Goetzl EJ, Weller PF, Sun FF: The regulation of human eosinophil function by endogenous mono-hydroxi-eicosatetraenoic acids (HETEs). J Immunol 124: 926–933, 1980. Google Scholar
Goetzl EJ: A role for endogenous mono-hydroxi-eicosatetraenoic acid (HETEs) in the regulation of human neutrophil migration. Immunology 40: 709–726, 1980. Google Scholar
O'Flaherty JT, Kreutzer DL, Showell HJ, Ward PA: Influences of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation. J Immunol 119: 1751–1756; 1977. Google Scholar
Grinnell F: Cellular adhesiveness and extracellular substrata. Int Rev Cytol 53:65–114, 1978. Google Scholar
Ozaki T, Yoshida K, Ushijima K, Hayashi H: Studies on the mechanisms of invasion in cancer. II: In vivo effects of a factor chemotactic for cancer cells. Int J Cancer 7: 93–100, 1971. Google Scholar
Lam WC, Delikatny EJ, Orr FW, Wass J, Varani J, Ward PA: The chemotactic response of tumor cells: A model for cancer metastasis. Am J Pathol 104: 69–76, 1981. Google Scholar
Orr FW, Lam WC, Delikatny EJ, Mokashi S, Varani J: Localization of 125-I-Iododeoxyuridine-labeled tumor cells at tissue sites injected with chemotactic stimuli. Invasion Metastasis (in press).
O'Flaherty JT, Showell HJ, Ward PA: Neutropenia induced by systemic infusion of chemotactic factors. J Immunol 118: 1586–1589, 1977. Google Scholar
O'Flaherty JT, Showell HJ, Kreutzer DL, Ward PA, Becker EL: Inhibition of in vivo and in vitro neutrophil responses to chemotactic factors by a competetive antagonist. J Immunol 120: 1326–1332, 1978. Google Scholar
Wood S: Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. Arch Pathol 66: 550–568, 1958. Google Scholar
Gospodarowics D, Delgado D, Vlodavsky I: Permissive effect of the extracellular matrix on cell proliferation in vitro. Proc Natl Acad Sci USA 77: 4094–4098, 1980. Google Scholar
Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degredation of basement membrane collagen. Nature 284: 67–68, 1980. Google Scholar
Garbisa S, Kniska K, Tryggvason K, Flotz C, Liotta LA: Quantitation of basement membrane collagen degredation by living tumor cells in vitro. Cancer Letters 9: 359–366, 1980. Google Scholar
Fantone J, Kunkel S, Varani J: Inhibition of tumor cell adherence by prostaglandins. In: Powels TJ, Bockman RS, Honn KV, Ramwell P (eds): Prostaglandins and related lipid, Vol. 2. Alan R. Liss, New York, pp 673–678, 1982. Google Scholar
Kunkel SL, Thrall RS, Kunkel RG, McCormick JR, Ward PA, Zurier RB: Suppression of immune complex vasculitis in rats by prostaglandins. J Clin Invest 64: 1525–1529, 1979. Google Scholar